Inici › Limfoma › Washington › Seattle
Assaigs clínics de Limfoma a Seattle, WA
12 estudis de Limfoma busquen participants en centres de Seattle i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
ReclutantFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutantFase 2
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
ReclutantEstudi observacional
- Fred Hutchinson, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Seattle Children s Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ReclutantFase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
ReclutantFase 1
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutantFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
ReclutantFase 1/2
- Dren Investigational Site, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
ReclutantEstudi observacional
- Seattle Children's Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutantFase 1/2
- University of Washington Medical Center, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ReclutantFase 2
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ReclutantFase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Assaigs de Limfoma en altres ciutats
- Houston, TX34 estudis
- Boston, MA33 estudis
- New York City, NY33 estudis
- Washington, DC23 estudis
- Baldwin Park, CA21 estudis
- Chicago, IL20 estudis
- Durham, NC17 estudis
- St. Louis, MO15 estudis
- Philadelphia, PA15 estudis
- Cleveland, OH14 estudis
- Edison, NJ12 estudis
- Atlanta, GA12 estudis
Altres estudis a Seattle
- Càncer de pulmó de cèl·lules no petites53 estudis
- Càncer (tots els tipus)49 estudis
- Càncer de pròstata42 estudis
- Leucèmia mieloide aguda40 estudis
- Càncer de mama39 estudis
- Càncer metastàtic39 estudis
- Càncer colorrectal34 estudis
- Càncer de pulmó33 estudis
- Càncer d'ovari30 estudis
- Mieloma múltiple22 estudis
- Síndromes mielodisplàsiques21 estudis
- Leucèmia limfoblàstica aguda21 estudis
De ClinicalTrials.gov, dades recuperades el 4 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.